Background
Approach
Diabetic retinopathy
Vascular transplants
Drug screening platform
Jobs
Team
News & Press
Contact
novel approaches to
vascular therapy
News & Press
Company News
Press releases
All
January 27, 2024
„Mit unserem Modell wollen wir Tierversuche ersetzen“
Learn more
October 21, 2023
"Organmodelle tanzen auf vielen Hochzeiten"
Learn more
October 19, 2023
Life Sciences Partnering 2023
Learn more
March 16, 2023
Building a biotech cluster in Innsbruck
Learn more
August 16, 2022
Tiroler Unternehmen entwickelt neue COPD-Therapie
Learn more
August 8, 2022
Angios and Harald Ott, M.D. launch Aerocyte
Learn more
March 24, 2022
LR Mattle: „Die Angios GmbH bereichert mit ihrer Diabetesforschung den Life Science-Sektor in Tirol“
Learn more
March 17, 2022
"Why organoids are playing a growing role in medical research"
Learn more
September 28, 2021
Angios is pleased to announce the partnership with panCELLa Inc. and its subsidiary, Implant Therapeutics,
Learn more
May 7, 2021
Penninger-Unternehmen Angios startet Diabetes-Forschung in Tirol
Learn more
May 6, 2021
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
Learn more
January 27, 2024
„Mit unserem Modell wollen wir Tierversuche ersetzen“
Learn more
October 21, 2023
"Organmodelle tanzen auf vielen Hochzeiten"
Learn more
October 19, 2023
Life Sciences Partnering 2023
Learn more
March 16, 2023
Building a biotech cluster in Innsbruck
Learn more
August 16, 2022
Tiroler Unternehmen entwickelt neue COPD-Therapie
Learn more
August 8, 2022
Angios and Harald Ott, M.D. launch Aerocyte
Learn more
March 24, 2022
LR Mattle: „Die Angios GmbH bereichert mit ihrer Diabetesforschung den Life Science-Sektor in Tirol“
Learn more
March 17, 2022
"Why organoids are playing a growing role in medical research"
Learn more
September 28, 2021
Angios is pleased to announce the partnership with panCELLa Inc. and its subsidiary, Implant Therapeutics,
Learn more
May 7, 2021
Penninger-Unternehmen Angios startet Diabetes-Forschung in Tirol
Learn more
May 6, 2021
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
Learn more
January 27, 2024
„Mit unserem Modell wollen wir Tierversuche ersetzen“
Learn more
October 21, 2023
"Organmodelle tanzen auf vielen Hochzeiten"
Learn more
October 19, 2023
Life Sciences Partnering 2023
Learn more
March 16, 2023
Building a biotech cluster in Innsbruck
Learn more
August 16, 2022
Tiroler Unternehmen entwickelt neue COPD-Therapie
Learn more
August 8, 2022
Angios and Harald Ott, M.D. launch Aerocyte
Learn more
March 24, 2022
LR Mattle: „Die Angios GmbH bereichert mit ihrer Diabetesforschung den Life Science-Sektor in Tirol“
Learn more
March 17, 2022
"Why organoids are playing a growing role in medical research"
Learn more
September 28, 2021
Angios is pleased to announce the partnership with panCELLa Inc. and its subsidiary, Implant Therapeutics,
Learn more
May 7, 2021
Penninger-Unternehmen Angios startet Diabetes-Forschung in Tirol
Learn more
May 6, 2021
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
Learn more